Peds rheumatologist. Mother. Wife. 🏖 & 🐶 lover. 👁🦵🏼researcher ➡️ #uveitis, #pedsrheum, #jia @CincyChildrens Views expressed are my own. 🇵🇭🇺🇸
Cincinnati, OH
Joined March 2018
- Tweets1.1K
- Following758
- Followers873
- Likes6.6K
Sheila Angeles-Han retweeted
Results of our recent study on Tofacitinib in JIA
@NetworkPrcsg @jaymehtamd @GrantSchulert @STHanMD @HermineBrunner0 @LauraLewMad11 @MymaAlbaydaMD @rheum_cat @Prahalpedrheum @HarryGewanter
No blood-based biomarkers could be identified to predict response to JAK inhibition (tofacitinib) in polyarticular JIA; however, an association of HLA-B27 positivity with lower tofacitinib response may warrant further study
In AC&R
loom.ly/EuPePSI
@PRheumdoc
ALT Supplemental Figure 1: Box plots of the levels of the log10-transformied CBB in 143 patients with JIA comparing responders (R; n = 50 ) to non-responders (NR; n = 93) at baseline and after 18 weeks of tofacitinib treatment.
Sheila Angeles-Han retweeted
Congratulations to all these amazing new @carrainc grant awardees including my @CincyChildrens colleagues @STHanMD Dani Schocken and Jackie Rodriguez-Smith! @CincyKidsOAACD @CincyResearch
🌟 Congratulations to the winners of this year's CARRA-Arthritis Foundation grants! Thank you to the @ArthritisFdn for partnering with us to help advance pediatric rheumatology research. Read the full story ➡️ carragroup.org/blog/arthriti…
Sheila Angeles-Han retweeted
.@Patricia_VegaF teaching elbow ultrasound with the newest Clarius hand held. Thanks @clariusmhealth for your support of our course #POCUS #ultrasound #medtwitter #rheumatology #joints #tendons – at Tampa, FL
Sheila Angeles-Han retweeted
Excited for our session in the @ARVOinfo Biomarkers Conference: OCT-based quantification of anterior chamber inflammation: what next?
Speakers:
➡️@lolaeyedoc @GoshSight
➡️SriniVas Sadda @DohenyEye
➡️@STHanMD @CincyChildrens
➡️Douglas Jabs @JohnsHopkinsSPH
➡️Me! @UCLASteinEye
Attention basic/clinician-scientists! Sign up for @ARVOinfo's virtual Biomarkers Conference (Nov. 8-9) to explore the current/future role of #biomarkers in diagnosing, treating and curing #oculardisorders. Register today: bit.ly/44rH0yV
#ARVOeducation #visionresearch
Sheila Angeles-Han retweeted
From @PittTweet @PittPubHealth @MassEyeAndEar @HMSEye @JohnKempen3 and collaborators:
No evidence of excess risk of cancer in patients who took immunosuppressant medications for inflammatory eye diseases (short-term courses). #NEIfunded
@BMJOncology: bit.ly/3OYZFMI
ALT Jeanine Buchanich, University of Pittsburgh, and John Kempen, Mass Eye and Ear
ALT Jeanine Buchanich, University of Pittsburgh, and John Kempen, Mass Eye and Ear
Sheila Angeles-Han retweeted
Do you or your child have #juvenilearthritis and are you 18 or older? If yes, please complete this brief survey surveymonkey.com/r/Y8C8HNY to help @carrainc & @ArthritisFdn select future research projects that matter most to you. Participation is completely voluntary #jiaresearch
Sheila Angeles-Han retweeted
The Foundation for Research in Rheumatology (FOREUM) and @RheumResearch are jointly issuing a call for apps highlighting funds to support research benefitting from collabs between investigators residing in both the U.S. and Europe. Info: rheumresearch.org/innovative…
Sheila Angeles-Han retweeted
Finally! Excited to see this in print:
Efficacy and safety of emapalumab in macrophage activation syndrome | Annals of the Rheumatic Diseases ard.bmj.com/content/early/20…
Sheila Angeles-Han retweeted
CALLING ALL PAEDIATRIC RHEUMATOLOGIST & RESEARCHERS 📣I am doing a presentation at PRSYM on collaboration and have put together a short 3 Q survey to collect opinions ‘Why, how and the future?’ I am sure you will all have very valuable ideas! Please see forms.office.com/e/h85fAAQXE…
Sheila Angeles-Han retweeted
In case you didn't know about grant funding:
If you have a current @NIH grant: you can obtain a #diversity supplement to provide support for research experiences of people (from HS to faculty levels) from diverse backgrounds.
Details & definitions: grants.nih.gov/grants/guide/…
Sheila Angeles-Han retweeted
The overall risk for hydroxychloroquine retinopathy was 8.6% after 15 years, and most cases were mild. Higher hydroxychloroquine dose was associated with progressively greater risk for incident retinopathy.
#ACPinternalmedicine #RheumTwitter
acpjournals.org/doi/pdf/10.7…
Sheila Angeles-Han retweeted
Attention below to Internal medicine/family medicine/Peds residents interested in a rheumatology rotation with me and colleagues at @BrighamWomens !
New 2- to 4-week rotation in rheumatology @BrighamWomens for URIM residents in internal medicine, med-peds, or family medicine! Residents participate in clinical care & learn about health equity in rheumatology. More info below; deadline 3/31. To apply: forms.office.com/r/kAiPhsMEK…
Sheila Angeles-Han retweeted
Register for now our @aao_ophth #uveitis webinar this Thursday, February 9, 8:30 - 10:00pm ET.
Topics include:
✅Anatomic location of uveitis
✅Grading of cells & haze
✅Granulomatous vs non-granulomatous
✅Onset, duration, & course
Last call: #Uveitis #CME webinar on Thursday, Feb. 9, 8:30 – 10 p.m. ET. Stay up to date on the latest standardized uveitis nomenclature (SUN) as experts discuss the grading of cells and haze, granulomatous versus non-granulomatous and more. ow.ly/OpA250MG7Rz
Sheila Angeles-Han retweeted
Here Comes the SUN: The 2023 Update on Uveitis store.aao.org/here-comes-the…
Join us on Thursday, Feb 9, 8:30-10PM ET
Topics covered in this @aao_ophth webinar:
➡️Anatomic location of #uveitis
➡️Grading of cells & haze
➡️Granulomatous vs non-granulomatous
➡️Onset, duration, & course
Sheila Angeles-Han retweeted
We are thrilled to have been part of a multi-institutional, multidisciplinary group to identify disease-associated T cells in #AnkylosingSpondylitis & Anterior #Uveitis that recognize antigens presented by HLA-B27, published in @Nature. (1/9)
Sheila Angeles-Han retweeted
Just published in @PIDJournal - our @CincyChildrens experience using tocilizumab in children and young adults with severe acute #COVID19
journals.lww.com/pidj/Fullte…
